Anavex Life Sciences (AVXL) Free Cash Flow (2010 - 2026)
Anavex Life Sciences' Free Cash Flow came in at -$9.1 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$12.46 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Free Cash Flow (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Anavex Life Sciences reported Free Cash Flow of -$29.29 million; for FY2025 (ended Sep 30, 2025), it was -$39.04 million.
- Going back by fiscal year, Free Cash Flow was -$30.81 million in FY2024, -$27.79 million in FY2023, -$24.24 million in FY2022 and -$30.38 million in FY2021.
- The five-year range for quarterly Free Cash Flow is -$12.46 million (fiscal Q3 2025) to -$3.5 million (fiscal Q1 2022).
- Business Quant data shows AVXL's Free Cash Flow at -$4.44 million (Q2 2026), -$7.15 million (Q1 2026) and -$8.6 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 6.20 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 5.34 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Anavex Life Sciences | 175.20 Mn | -304.88 Mn | - | -9.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.10 Mn |
| Mar 31, 2026 | -4.44 Mn |
| Dec 31, 2025 | -7.15 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -12.46 Mn |
| Mar 31, 2025 | -5.86 Mn |
| Dec 31, 2024 | -12.12 Mn |
| Sep 30, 2024 | -6.66 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Mar 31, 2024 | -11.66 Mn |
| Dec 31, 2023 | -7.32 Mn |
| Sep 30, 2023 | -5.85 Mn |
| Jun 30, 2023 | -7.65 Mn |
| Mar 31, 2023 | -8.49 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -4.04 Mn |
| Jun 30, 2022 | -7.05 Mn |
| Mar 31, 2022 | -9.64 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Sep 30, 2021 | -7.67 Mn |
API Access
Anavex Life Sciences Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();